Skip to main content
. Author manuscript; available in PMC: 2021 May 1.
Published in final edited form as: Diagn Microbiol Infect Dis. 2020 Jan 21;97(1):114996. doi: 10.1016/j.diagmicrobio.2020.114996

Table 3:

Performance of genotypic resistance data for prediction of phenotypic antimicrobial resistance in Klebsiella pneumoniae.

Antibiotic Sensitivity (%) Specificity (%) % agreement (CI) PPV (100%) NPV (100%)
Ampicillin 100 N/A 100 (91.2– 100) 100 N/A
Ceftriaxone 100 N/A 100 (91.2– 100) 100 N/A
Ceftazidime 100 N/A 100 (91.2–100) 100 N/A
TMP/SMX 91.9 33.3 87.5 (73.2–95.8) 94.4 25
Ciprofloxacin 97.3 66.6 95 (83.1–99.4) 97.3 66.67
Gentamicin 24.1 100 45 (29.2–61.5) 100 33.3
Meropenem 100 N/A 100 (91.2–100) 100 N/A
Levofloxacin 100 100 100 (91.19–100) 100 100
Cefepime 100 N/A 97.5 (86.8–99.9) 97.5 N/A
Tobramycin 100 100 100 (91.2– 100) 100 100
Ertapenem 100 N/A 100 (91.2– 100) 100 N/A
Cefazolin 100 N/A 100 (91.2– 100) 100 N/A
Aztreonam 100 N/A 100 (91.2– 100) 100 N/A
Total 94.7 88 94.4 (92.0–96.2) 99.4 45.8

PPV, positive predictive value; NPV, negative predictive value; CI, confidence intervals; N/A, not available